A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy in the battle to quit smoking. Smokers trying to quit face potent side effects from nicotine withdrawal, including cravings, increased